Evaluation of Mobiderm Intimate Bra in the Management of Breast Edema Related to Breast Cancer Treatment
Condition(s) studied
Investigational drug(s) / intervention(s)
Mobiderm Intimate Bra group: At the conclusion of the surgical operation, MOBIDERM Intimate bra will be placed on the patient by the medical team. It will be recommended for the patients to wear MOBIDERM Intimate Bra during day and night for 3 weeks after the surgery, and as much time as the patients tolerate the device during the rest of the study, until 6 months after radiotherapy
Study summary
The aim of this exploratory study is to assess the performance and tolerability of the MOBIDERM Intimate Bra in the management of breast edema related to breast cancer treatment.
Eligibility
Primary outcome measure(s)
- Evolution of breast edema severity — Between 35 and 44 weeks (6 months after radiotherapy)
The evolution of breast edema severity will be assessed all along the study follow-up using the patient-completed "Symptoms" section of the Breast Edema Questionnaire (BrEQ): 8 questions about symptoms of breast edema scored on a scale from 0 to 10 (0 = no difficulty and 10: maximal difficulty). The maximum score is 80 .
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Groupe Hospitalier Paris Saint Joseph - Groupement FEHAP | Paris | Paris 14 |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06303154 on ClinicalTrials.gov ↗ ← All trials in France